The S&P 500 has climbed 10 per cent in two weeks, and is now just below where it was on Liberation Day. But the trade stoush ...

In a recent landmark ruling, Schmidt v. Schmidt, Kirifides and Rassias (Workers’ Compensation Appeal Board), the Pennsylvania ...

The financial health of hospitals, health systems, and Integrated Delivery Networks (IDNs) is increasingly challenged by the complexities of Revenue Cycle Management (RCM). As healthcare costs rise ...

In fact, there is no specific mattress that’s best for back pain. Instead, people with back pain should look for mattresses that feel medium-firm to you. Those beds have the best chance of ...

The NeuroOne OneRF Ablation System is a new device with FDA-cleared technology designed for both diagnosing and treating ...

Billed on Wall Street as so rock-solid safe they’re risk-free, US Treasury bonds have long served as first port of call for investors during times of panic. They rallied during the global financial ...

On the day of the hearing, Darshan’s legal counsel informed the court that the actor could not appear due to severe back pain. The court had expressed displeasure and reiterated that personal ...

Meanwhile, back pain is one of the leading causes of ... mindfulness-based practices as an alternative to opioid use for pain management could potentially help reduce the opioid epidemic.

China’s energy storage industry faces a double whammy to its sales prospects from punitive US tariffs and scaled-back support from the government in its domestic market. Batteries used to store ...

Last year, he won the Jack Adams Award, and this year, I think he’s probably been even better. But whatever he does, it’s his decision. Obviously, I’d like to have him back. And I think he knows that.

Since Trump unveiled his tariffs late on Wednesday, S&P 500 companies have lost almost $6 trillion in stock market value, a record four-day decline for the benchmark going back to the 1950s Trump ...

Pregabalin Gel 8%, a topical formulation designed for the effective management of diabetic neuropathic pain, received regulatory approval from the Central Drugs Standard Control Organization (CDSCO) ...